| Secondary |
| Drug Use For Unknown Indication |
50.4% |
| Pemphigoid |
15.3% |
| Cellulitis |
7.6% |
| Vitamin Supplementation |
7.6% |
| Pemphigus |
5.3% |
| Constipation |
4.6% |
| Hypertension |
4.6% |
| Hiv Infection |
2.3% |
| Mycobacterial Infection |
2.3% |
|
| Interstitial Lung Disease |
25.0% |
| Mania |
16.7% |
| Hepatic Enzyme Increased |
8.3% |
| Ill-defined Disorder |
8.3% |
| Platelet Count Decreased |
8.3% |
| Pruritus Generalised |
8.3% |
| Renal Failure Acute |
8.3% |
| Tinea Versicolour |
8.3% |
| Urticaria |
8.3% |
|
| Concomitant |
| Pemphigoid |
15.4% |
| Drug Use For Unknown Indication |
14.2% |
| Product Used For Unknown Indication |
13.7% |
| Crohn's Disease |
6.0% |
| Multiple Myeloma |
6.0% |
| Hypertension |
5.5% |
| Hepatitis C |
4.2% |
| Pain |
3.7% |
| Anorexia |
3.5% |
| Osteoporosis Prophylaxis |
3.5% |
| Prophylaxis |
3.5% |
| Depression |
3.2% |
| Diabetes Mellitus |
3.2% |
| Psoriasis |
2.5% |
| Non-small Cell Lung Cancer |
2.2% |
| Hypokalaemia |
2.0% |
| Mood Altered |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
| Vomiting |
2.0% |
| Anxiety |
1.7% |
|
| Vomiting |
12.9% |
| White Blood Cell Count Increased |
8.1% |
| Aspartate Aminotransferase Increased |
6.5% |
| Hepatitis C |
6.5% |
| Weight Decreased |
6.5% |
| Abdominal Discomfort |
4.8% |
| Gastrointestinal Perforation |
4.8% |
| Hypotension |
4.8% |
| Renal Failure |
4.8% |
| Reversible Posterior Leukoencephalopathy Syndrome |
4.8% |
| Staphylococcal Sepsis |
4.8% |
| Visual Impairment |
4.8% |
| Alanine Aminotransferase Increased |
3.2% |
| Cardiac Failure Congestive |
3.2% |
| Drug Interaction |
3.2% |
| Gastric Haemorrhage |
3.2% |
| Granulocytopenia |
3.2% |
| Hepatitis Acute |
3.2% |
| Interstitial Lung Disease |
3.2% |
| Kidney Infection |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Palmar-plantar Erythrodysaesthesia Syndrome |
100.0% |
|
